USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventures led the company to lower its full-year outlook.